Device development partner trusted by 9 out of the top 10 pharma companies

For 40 years, Team Consulting has partnered with global pharmaceutical and medical device companies to develop market‑leading drug delivery devices. Drawing on an in-depth knowledge of drug delivery systems, from novel, targeted delivery to parenteral and respiratory devices manufactured at scale, we help you create high-performing, user‑centred devices and combination products that improve patient outcomes and deliver commercial success.

Novel drug delivery technology development

Working from early opportunity discovery to device verification, industrialisation and launch, we bring the speed, agility and deep expertise you need to drive progress, de-risk your development and meet your timelines.

With in-house specialists across systems engineering, design, human factors, manufacturing, device testing, quality engineering and project management, we offer an unparalleled balance of expertise to ensure your device is robust, user-centred and ready for market.

All our work is delivered under a rigorously maintained ISO 13485:2016 certified quality management system, giving you complete confidence in compliance, reliability and excellence throughout your development journey.

Platform device evaluation

Our focus is on helping you find the right solution for your needs, whether that’s licensing an existing platform, or developing a novel technology from concept to launch.

Tapping into our in-depth knowledge built on 630+ drug delivery projects, we provide impartial, expert insight to help you evaluate the most suitable delivery technology for your therapy. Our team brings fresh thinking and deep technical understanding across key strategic areas, including:

device selection strategy
detailed platform evaluation
technical due diligence
post launch support
cost reduction modelling
digital patient support

We help you unlock value at every stage, giving you the evidence, clarity and confidence to move forward with the best solution for your programme.

Supporting you across the drug delivery landscape

Digital health

Whether you’re integrating digital biomarkers for clinical trials or deploying digital tools to improve patient outcomes, we enhance drug delivery solutions through advanced digital health. We design end‑to‑end digital experiences that integrate physical products and digital touchpoints across the patient and HCP ecosystem – from connected drug delivery devices, smart packaging and digital patient engagement solutions to apps, training and connected services.

Drawing on deep expertise in UX design and behavioural science, we identify where digital solutions create genuine value. Informed by continuous user feedback, our teams integrate SaMD across remote monitoring and connected device ecosystems to deliver seamless, behaviour‑led UX/UI that fits naturally into people’s lives, optimise safety, usability, onboarding and long‑term engagement, and support sustained behaviour change.

Nasal

With extensive expertise in nasal drug delivery device development, we support clients from early concept through scale up and design verification, helping you overcome hurdles and achieve your milestones – faster.

Our experience spans landscaping and device selection for intranasal delivery, production troubleshooting, and issue resolution in nasal spray manufacturing. We also support the development and pilot production of novel intranasal delivery technologies, ensuring robust performance, manufacturability and user centred design. Our multidisciplinary teams bring engineering rigour, human factors insight and applied science to help you overcome key challenges, from droplet formation and deposition, to usability and regulatory submission.

Ocular

With over 15 years of ocular drug delivery experience, we have supported pharma and biotech companies across 36+ ocular projects and 800+ human factors sessions, including work with more than 650 ophthalmology clinicians. Our expertise spans sprays, vial kits, pre-filled syringes, sustained release implants, subretinal and transvitreal delivery, as well as digital tools supporting advanced ophthalmic therapies.

We provide end to end development and specialist support – from early concept generation and technology scouting to usability studies, design optimisation, risk management and regulatory preparation. Our experts help you create safe, intuitive and effective ocular delivery systems that meet the needs of both clinicians and patients.

Parenteral

Built on 630+ injectable projects for 70+ global clients, we help you add speed, agility and regulatory rigour to your parenteral device development. Working from early opportunity discovery to verification, industrialisation and launch, we bring a deep experience across auto-injectors, pre-filled syringes, on-body and complex combination products to your development.

With a proven ability to de-risk technical, usability and regulatory challenges, our focus is on helping you reduce development costs and confidently navigate critical decisions to achieve robust, commercially successful parenteral solutions.

Pulmonary

Delivering end to end expertise in pulmonary drug delivery devices, we support clients from early concepting through pilot production and design verification. Our experience spans novel pMDIs, blister based multi dose DPIs, capsule based DPIs and soft mist inhalers, including troubleshooting, device selection and scale up.

From overcoming challenges in aerosol performance, to improving manufacturability, user interaction and navigating regulatory pathways, we help you create robust, reliable and patient centric solutions. Combining engineering rigour, human factors insight and applied science, we optimise device design for consistency, usability and commercial success – whether improving existing platforms or developing next generation inhalation technologies.

Targeted drug delivery

Built on a deep, multi disciplinary expertise in targeted drug delivery systems, we support clients across oncology, surgical delivery, ocular therapies and cell and gene therapies. Our work spans intratumoral delivery of liquids and solids, image guided delivery deep within cranial tissue, direct to organ and catheter based delivery. We also have experience in advanced tissue modelling and biosensor development to optimise dose placement and distribution.

Combining engineering rigour with applied science, we use in silico modelling, empirical tissue characterisation and multi modal imaging to ensure precise, repeatable and safe delivery at the target site. This allows us to help clients unlock complex therapies that cannot be delivered systemically.

Design for high-volume production

Maintaining effective usability, design and reliability at high‑volume production requires a careful balance of industrial design and robust engineering. We help you create drug delivery devices that are high performing, compliant and optimised for efficient manufacture and assembly at scale.

Our approach integrates production readiness from the earliest stages of development, using proven DFM and DFA methods, tolerance analysis and process‑based risk assessment to ensure designs are commercially viable. Supported by our global network of approved suppliers and close collaboration with leading CMOs or your existing manufacturing partners, we help translate design intent into reliable, high‑volume commercial production.

Supporting your regulatory approval

Navigating the regulatory landscape of a drug delivery device is complex. Our consultants bring specialist knowledge in European and FDA regulations and are active members on several ISO working groups. This in-depth expertise of drug delivery regulations allows us to guide your approval strategy from concept to launch, helping you to accelerate your path to market.

Bespoke, high-tech and flexible laboratories to test complex devices

Our high-tech laboratories offer the flexibility to create bespoke environments adapted to handle and test complex devices. We have over 5500 sq. ft. of lab space in our on-site facilities, including dedicated environmental labs (ISO 20072 certified) and biological containment level 1 labs with state-of-the-art testing apparatus.

Sustainable drug delivery solutions

Team has a dedicated sustainability group that challenges the way medical devices are designed, to help you develop drug delivery technologies that will mitigate greenhouse gas emissions and limit waste. Applying rigorous Life Cycle Analysis (LCA), we advise on material selection, manufacturing, transportation and more, allowing you to apply sustainable approaches at all stages of your device’s life.

Meet our drug delivery experts

Chris Hurlstone - Director of Drug Delivery

Chris has 30 years of experience in the development of medical devices, with a focus on drug delivery: inhalers, injectors and on-body delivery systems.

His expertise spans all phases of development from strategy, planning and requirements capture to industrialisation, design transfer and post-market support. Chris regularly presents at international conferences and is a member of ISO committee TC84 for drug delivery devices.

Explore

John Burke - Managing Consultant, Drug Delivery

John is an experience consultant specialising in the design and delivery of complex drug delivery devices, particularly parenteral systems. He works closely with clients to balance technical, user and commercial requirements to produce simple, elegant solutions.

Drawing on extensive experience with leading pharma companies in Europe and the US, John brings strong market insight to develop robust, user centred devices that perform reliably from development through to use.

Explore